Dimensional Fund Advisors LP Sells 13,429 Shares of Psychemedics Co. (NASDAQ:PMD)

Dimensional Fund Advisors LP cut its holdings in Psychemedics Co. (NASDAQ:PMD) by 37.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,688 shares of the company’s stock after selling 13,429 shares during the period. Dimensional Fund Advisors LP’s holdings in Psychemedics were worth $55,000 as of its most recent SEC filing.

Psychemedics Price Performance

Shares of PMD stock opened at $2.31 on Wednesday. The company has a market capitalization of $13.44 million, a price-to-earnings ratio of -3.01 and a beta of 0.66. Psychemedics Co. has a one year low of $1.63 and a one year high of $3.93. The company’s fifty day moving average price is $2.26 and its 200-day moving average price is $2.39.

Psychemedics (NASDAQ:PMD) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.14) earnings per share (EPS) for the quarter. The company had revenue of $4.73 million during the quarter. Psychemedics had a negative net margin of 21.50% and a negative return on equity of 68.43%.

Psychemedics Company Profile

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol.